Abstract CN93
Background
Despite the significant survival benefits offered by immune checkpoint inhibitors (ICIs) in advanced non-small cell lung cancer (NSCLC), disease progression is inevitable. A diverse patient-reported QOL scale attempts to predict outcomes for ICI-treated NSCLC patients using machine learning.
Methods
This study analyzed three multicenter trials of atezolizumab (anti-PD-L1) in NSCLC patients with completed baseline EORTC QLQ-C30 V3 and QLQ-LC13 scales. The phase III IMpower150 cohort served as the discovery set, while the phase II BIRCH and phase III OAK cohorts were used for validation. MOVICS was used to compute cluster analysis and cluster predictor indices (CPI). Predictive ability was assessed with time-dependent AUC, validated with external datasets (OAK, BIRCH) using the PAM algorithm.
Results
In the IMpower150 Discovery Set, using ten consensus ensemble clustering algorithms with QOLS data, two subtypes emerged: Cluster 1 (CS1) and Cluster 2 (CS2). CS2 patients had shorter median overall survival (13.14 vs. 21.42 months, hazard ratio [HR] 2.07 [1.64-2.62]; P < 0.0001) and progression-free survival (5.7 vs. 8.3 months, HR 1.70 [1.42-2.04]; P < 0.0001) compared to CS1. Clinical benefit rates for CS2 were 57% compared to 68% for CS1 (P=0.0027). The PAM algorithms were validated with a similar variety of outcomes in external cohorts. CS2 consistently predicted unfavorable OS (OAK, P < 0.0001; BIRCH, P < 0.0001) and PFS (OAK, P = 0.032; BIRCH, P < 0.0001) compared to CS1.
Conclusions
Our study demonstrated the promise of integrative machine learning to effectively analyze QOLS. This approach could be used to predict clinical outcomes in advanced NSCLC patients undergoing atezolizumab immunotherapy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
This research was funded by the National Natural Science Foundation of China, Grant No. 82060475; Chunhui program of the Chinese Ministry of Education, Grant No. HZKY20220231; the Natural Science Foundation of Guizhou Province, Grant No. ZK2022-YB632; Youth Talent Project of Guizhou Provincial Department of Education, Grant No. QJJ2022-224; China Lung Cancer Immunotherapy Research Project, Excellent Young Talent Cultivation Project of Zunyi City, Zunshi Kehe HZ (2023) 142; Future Science and Technology Elite Talent Cultivation Project of Zunyi Medical University, ZYSE-2023-02; Collaborative Innovation Center of Chinese Ministry of Education, Grant No. 2020-39.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN94 - Associations between depression and quality of life after hematopoietic stem cell transplantation: A longitudinal study
Presenter: Arianna Rosich-Soteras
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN95 - A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer
Presenter: Yang Sun
Session: EONS Poster Display session
Resources:
Abstract
CN96 - Patient education to support self-management and self-efficacy during immunotherapy: An integrative review
Presenter: Camilla Rothausen
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN97 - Impact of a proactive telephone intervention led by the advanced practice nurse aimed at symptom control and toxicity detection on the quality of life of outpatients with lung cancer undergoing treatment
Presenter: Isabel Brao Perez
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN98 - The health gains of therapeutic touch in cancer patients with pain: A literature review
Presenter: Helga Martins
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN99 - Nursing management of cancer treatment related peripheral neuropathy
Presenter: Georgios Tsagkanis
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN100 - Scalp cooling in breast cancer: What are women's experiences? A description and qualitative study
Presenter: Maria Rosaria Esposito
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN101 - Continuous care unit for patients with cancer: Identification of the user profile and follow-up needs
Presenter: Irene Casablancas
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN103 - Is my patient constipated? How do I assess? Validity and reliability study of the constipation assessment scale in cancer patients: The case of Türkiye
Presenter: Aslıhan Öztürk Çetin
Session: EONS Poster Display session
Resources:
Abstract
CN104 - Exercise interventions in the management of chemotherapy-induced peripheral neuropathy
Presenter: İlayda Eroğlu
Session: EONS Poster Display session
Resources:
Abstract
Slides